Gastrointestinal complications after 3 months of dual antiplatelet therapy for drug-eluting stents as assessed by wireless capsule endoscopy

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 2, 2009, Pages 171-176

  Seddighzadeh, Ali ^a   Wolf, Anne T ^a   Parasuraman, Sudha ^a   Shetty, Ranjith ^c   Vallurupalli, Neelima ^d   Reddy, Sarathchandra ^b   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiplatelent agents; Aspirin; Clopedogel; Drug eluting coronary stents; Gastric erosions

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; DIGESTIVE SYSTEM INJURY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEARTBURN; HEMATOCHEZIA; HUMAN; MALE; NAUSEA; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STOMACH EROSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CAPSULE ENDOSCOPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64649091422     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608325545     Document Type: Article

References (18)

1. Patrono C., Garcia Rodriguez LA, Landolfi R., Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005 ; 353: 2373-2383. (Pubitemid 41713749)
2. Antithrombotic Trialists ' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002 ; 324: 71-86. (Pubitemid 34073138)
3. Mehta SR, Yusuf S., Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001 ; 358: 527-533. (Pubitemid 32772726)
4. Yusuf S., Zhao F., Mehta SR, Chrolavicius S., Tognoni G., Fox KK Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001 ; 345: 494-502.
5. Steinhubl SR, Berger PB, Mann JT 3rd, et al. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002 ; 288: 2411-2420.
6. Eshaghian S., Kaul S., Amin S., Shah PK, Diamond GA Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med. 2007 ; 146: 434-441.
7. Vane JR, Botting RM The mechanism of action of aspirin. Thromb Res. 2003 ; 110: 255-258. (Pubitemid 37329821)
8. Vane JR Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 ; 231: 232-235.
9. Gachet C., Stierle A., Cazenave JP, et al. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man. Biochem Pharmacol. 1990 ; 40: 229-238.
10. Mills DC, Puri R., Hu CJ, et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb. 1992 ; 12: 430-436.
11. Vallurupalli NG, Goldhaber SZ Gastrointestinal complications of dual antiplatelet therapy. Circulation. 2006 ; 113: e655 - e658.
12. Weil J., Colin-Jones D., Langman M., et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995 ; 310: 827-830.
13. Grines CL, Bonow RO, Casey DE Jr, et al. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007 ; 115: 813-818.
14. Fork FT, Lafolie P., Tóth E., Lindg signrde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scand J Gastroenterol. 2000 ; 35: 464-469. (Pubitemid 30354084)
15. Ma L., Elliott SN, Cirino G., Buret A., Ignarro LJ, Wallace JL Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A. 2001 ; 98: 6470-6475. (Pubitemid 32488261)
16. Rosenstock SJ, Jorgensen T. Prevalence and incidence of peptic ulcer disease in a Danish County-a prospective cohort study. Gut. 1995 ; 36: 819-824.
17. Yeomans ND, Lanas AI, Talley NJ, et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 ; 22: 795-801. (Pubitemid 41564359)
18. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005 ; 352: 238-244. (Pubitemid 40110812)